[Currently used positive inotropic substances].
D002316:Cardiotonic Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003327:Coronary Disease / Q000188:drug therapy*; D004280:Dobutamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D004298:Dopamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D004837:Epinephrine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use
D002316:Cardiotonic Agents; D004280:Dobutamine; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
Neuere positiv inotrope Substanzen.